chidamide
Showing 51 - 75 of 77
Diffuse Large B-cell Lymphoma Trial in ZhengZhou (Chidamide, Vinorelbine, Liposomal Doxorubicin or mitoxantrone)
Unknown status
- Diffuse Large B-cell Lymphoma
- Chidamide
- +4 more
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 31, 2020
Cutaneous T-cell Lymphoma Trial in Beijing (Sintilimab, Chidamide)
Recruiting
- Cutaneous T-cell Lymphoma
- Sintilimab
- Chidamide
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 4, 2020
Chronic HIV Trial in Xi'an (Chidamide)
Completed
- Chronic HIV Infections
- Chidamide
-
Xi'an, Shaanxi, ChinaDepartment of Infectious Diseases, Tangdu Hospital, The Fourth M
Jan 12, 2020
Peripheral T-cell Lymphoma Trial in Beijing (Chidamide, cyclophosphamide, adriacin)
Completed
- Peripheral T-cell Lymphoma
- Chidamide
- +4 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jul 22, 2019
AML Trial in Tianjin (Cytarabine, Chidamide)
Recruiting
- AML
- Cytarabine
- Chidamide
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Mar 21, 2019
Thrombocytopenia Trial in Jinan (Chidamide)
Unknown status
- Thrombocytopenia
- Chidamide
-
Jinan, Shandong, ChinaQilu hospital, Shandong University
Feb 11, 2019
Experimental Tumor Trial in Beijing (Chidamide, Cyclophosphamide, Doxorubicin)
Recruiting
- Experimental Tumor
- Chidamide
- +5 more
-
Beijing, ChinaBeijing Cancer Hospital
Aug 30, 2018
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Beijing (chidamide)
Unknown status
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- chidamide
-
Beijing, Beijing, ChinaCancer Hospital and Institute, Chinese Academy of Medical Scienc
Aug 10, 2018
Experimental Tumor Trial in Beijing (Chidamide)
Not yet recruiting
- Experimental Tumor
- Chidamide
-
Beijing, Beijing, ChinaBeijing
Aug 1, 2018
Extranodal NK/T-cell Lymphoma Trial in Chengdu (tofacitinib, chidamide)
Unknown status
- Extranodal NK/T-cell Lymphoma
- tofacitinib
- chidamide
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jul 24, 2018
Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial (Chidamide, Cladribine, gemcitabine)
Unknown status
- Hodgkin Lymphoma
- Non-hodgkin Lymphoma
- Chidamide
- +4 more
- (no location specified)
Jul 25, 2018
Leukemia, Acute, MDS Trial in Chengdu (Chidamide, Cyclophosphamide, cyclosporine A)
Unknown status
- Leukemia, Acute
- MDS
- Chidamide
- +2 more
-
Chengdu, Sichuan, China
- +1 more
Jul 17, 2018
Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma Trial in Guangzhou (drug, procedure, radiation, genetic, diagnostic
Unknown status
- Leukemia
- +7 more
- Dexamethasone
- +20 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology, Nanfang Hospital
Jun 11, 2018
Leukemia, Acute, Leukemia, T Cell, Leukemia, Lymphoblastic Trial in Guangzhou (drug, procedure, radiation, genetic, diagnostic
Unknown status
- Leukemia, Acute
- +2 more
- Chidamide
- +19 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Jun 11, 2018
Experimental Tumor Trial in Guangzhou (Chidamide)
Unknown status
- Experimental Tumor
- Chidamide
-
Guangzhou, Guangdong, ChinaCancer Center of Sun Yat-Sen University (CCSU)
Apr 4, 2018
Lymphoma Trial in China (Chidamide, Cladribine, gemcitabine)
Unknown status
- Lymphoma
- Chidamide
- +4 more
-
Beijing, Beijing, China
- +17 more
Jul 16, 2018
Experimental Trial (Chidamide)
Unknown status
- Experimental
- Chidamide
- (no location specified)
Jan 23, 2018
Peripheral T Cell Lymphoma Trial in Shanghai (Chidamide)
Unknown status
- Peripheral T Cell Lymphoma
- Chidamide
-
Shanghai, Shanghai, ChinaRuijin Hospital
Nov 10, 2017
Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Doxorubicin)
Unknown status
- Diffuse Large B-cell Lymphoma
- Rituximab
- +5 more
-
Shanghai, Shanghai, ChinaShanghai Ruijin Hospital
Nov 10, 2017
Peripheral T-cell Lymphoma Trial in Guangzhou (Chidamide, prednisone, Cyclophosphamide)
Unknown status
- Peripheral T-cell Lymphoma
- Chidamide
- +4 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology,Sun Yat-Sen University Cancer Cen
Oct 23, 2017
Angioimmunoblastic T-cell Lymphoma Trial in Qingdao (Chidamide)
Unknown status
- Angioimmunoblastic T-cell Lymphoma
- Chidamide
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Sep 20, 2017
Adenocystic Carcinoma Trial in Beijing (Chidamide)
Unknown status
- Adenocystic Carcinoma
- Chidamide
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Aug 30, 2017
Peripheral T Cell Lymphoma Trial in Suzhou (Chidamide)
Unknown status
- Peripheral T Cell Lymphoma
- Chidamide
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Aug 30, 2017
Peripheral T Cell Lymphoma Trial in Guangzhou (chidamide, cyclophosphamide, liposomal doxorubicin)
Unknown status
- Peripheral T Cell Lymphoma
- chidamide
- +4 more
-
Guangzhou, Guangdong, ChinaRu Feng
Jan 13, 2017
T Cell Non-Hodgkin's Lymphoma Trial in Beijing, Tianjin (Chidamide, Cyclophosphamide, Epirubicin)
Recruiting
- T Cell Non-Hodgkin's Lymphoma
- Chidamide
- +5 more
-
Beijing, Beijing, China
- +1 more
Dec 6, 2016